Survey Suggests Industry Aversion To Facility Registration Fee
This article was originally published in The Gray Sheet
Executive Summary
More than 60% of 21 medical device firms surveyed last year opposed the idea of an FDA facility Registration fee as an alternative to premarket submission fees, according to a 1report issued May 23